FDA’s New PSG Batch Features GSK’s Inhalers
New Guidance Documents Issued on HIV, ALS, Oncology, And Opioid Overdose Generics
In its latest batch of product-specific guidances, the FDA released multiple new and revised guidances on inhalers, including several on GSK’s products such as Relenza and the Ellipta trio.
